$RNAC
Cartesian Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$6.68
▼-1.04%-$0.070
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCartesian Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RNAC down today? It is at $6.68 (-1.04%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNAC spikes, and full due diligence on RNAC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RNAC 16 times in the last 30 days. Create a free account to track $RNAC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
RNAC is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on RNAC today, peaking at 3.7x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kalayoglu Murat Beneficial Owner (10%) | Other | 758K 2.5% of company | added 17% | 5.31M | n/a | Apr 2, 26 |
Hoge Elizabeth Beneficial Owner (10%) | Other | 758K 2.5% of company | added 15% | 5.82M | n/a | Apr 2, 26 |
Singer Michael Director | Sold (automatic/other) | -7K 0.02% of company | sold 12% | 50K | n/a | Mar 13, 26 |
Davis Blaine Officer | Sold (automatic/other) | -11K 0.04% of company | sold 8.0% | 121K | $72K at $6.82 | Jan 6, 26 |
Miljkovic Milos Officer | Sold (automatic/other) | -4K 0.01% of company | sold 5.7% | 59K | $24K at $6.82 | Jan 6, 26 |
Brunn Carsten Officer | Sold (automatic/other) | -24K 0.08% of company | sold 6.8% | 324K | $162K at $6.82 | Jan 6, 26 |
Kalayoglu Murat Director | Acquired (grant/award) | +3K | added 0.5% | 512K | n/a | Jan 2, 26 |
Springer Timothy A Director | Acquired (grant/award) | +3K | added <0.1% | 8.65M | n/a | Jan 2, 26 |
Singer Michael Director | Acquired (grant/award) | +3K | added 4.9% | 56K | n/a | Jan 2, 26 |
English Emily Officer | Acquired (grant/award) | +24K 0.08% of company | added 34% | 94K | n/a | Jan 2, 26 |
Barabe Timothy C Director | Acquired (grant/award) | +3K | added 4.8% | 57K | n/a | Jan 2, 26 |
Davis Blaine Officer | Acquired (grant/award) | +37K 0.1% of company | added 39% | 132K | n/a | Jan 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
RNAC is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on RNAC today, peaking at 3.7x its normal volume.
RNAC last traded at $6.68, down 1.04% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cartesian Therapeutics, Inc. Common Stock (RNAC) is next expected to report earnings on Thursday, November 5, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RNAC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNAC 16 times in the last 30 days.
RNAC (Cartesian Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $204M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNAC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RNAC discussion
Sign in to ask a question or join the discussion.